View Older Stories

Feb 13, 2026 04:50PM Amgen (AMGN) files mixed shelf

Feb 12, 2026 03:54PM Freedom Capital Markets Downgrades Amgen (AMGN) to Hold (mid morning)

Feb 6, 2026 07:29AM Amgen (AMGN) PT Raised to $347 at Guggenheim

Feb 4, 2026 12:27PM BofA on Amgen (AMGN): 'Catalysts: pelacarsen readthrough shifts to mid-2026'

Feb 4, 2026 09:59AM Amgen (AMGN) PT Raised to $350 at Cantor Fitzgerald

Feb 4, 2026 08:10AM Amgen (AMGN) PT Raised to $360 at RBC Capital

Feb 4, 2026 05:37AM Amgen (AMGN) PT Raised to $420 at TD Cowen

Feb 3, 2026 04:30PM After-hours movers: AMD, Chipotle, Lumentum, Silicon Labs and more

Feb 3, 2026 04:02PM Amgen (AMGN) Tops Q4 EPS by 56c, Beats on Revenue; Offers FY26 Guidance

Feb 3, 2026 10:32AM Amgen (AMGN) call put ratio 1 call to 1 put into quarter results

Feb 3, 2026 05:37AM Amgen (AMGN) call put ratio 1.1 calls to 1 put into quarter results

Feb 2, 2026 10:30AM Amgen (AMGN) call put ratio 2.3 calls to 1 put into quarter results

Feb 2, 2026 05:09AM Amgen (AMGN) call put ratio 1 call to 1.4 puts into quarter results

Jan 30, 2026 11:17AM Amgen (AMGN) call put ratio 1 call to 1.6 puts into quarter results

Jan 21, 2026 10:00AM This U.S. biotech stock is Bernstein's Top Pick for 2026

Jan 20, 2026 09:21AM Bernstein SocGen Group Downgrades Amgen (AMGN) to Market Perform

Jan 13, 2026 05:35AM Amgen (AMGN) PT Raised to $304 at BofA Securities

Jan 8, 2026 11:18AM Amgen (AMGN) call put ratio 1 call to 5.3 puts into the annual J.P. Morgan Healthcare Conference

Jan 7, 2026 04:58AM UBS Assumes Amgen (AMGN) at Buy

Jan 6, 2026 09:01AM Amgen acquires Dark Blue Therapeutics for up to $840 million

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 19, 2025 02:24PM Amgen expands direct-pay program, cuts drug prices up to 80%

Dec 19, 2025 02:24PM 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 19, 2025 08:51AM White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'

Dec 17, 2025 06:38AM Oppenheimer Upgrades Amgen (AMGN) to Outperform

Dec 9, 2025 04:02PM Amgen (AMGN) Declares $2.52 Quarterly Dividend; 3.2% Yield

Dec 5, 2025 09:24AM Erste Group Upgrades Amgen (AMGN) to Buy

Dec 3, 2025 04:11AM Amgen (AMGN) PT Raised to $372 at BMO Capital

Nov 26, 2025 06:36AM Bernstein on IRA pricing: $245 really is the floor

Nov 25, 2025 05:07AM Goldman Sachs Reiterates Buy Rating on Amgen (AMGN)

Nov 19, 2025 04:02PM FDA grants full approval for Amgen's IMDELLTRA in lung cancer

Nov 14, 2025 07:55AM Amgen (AMGN) PT Raised to $381 at Piper Sandler

Nov 6, 2025 10:14AM Amgen (AMGN) PT Raised to $315 at Cantor Fitzgerald

Nov 5, 2025 07:15AM Piper Sandler on Amgen (AMGN): 'Continued Strong Commercial Execution Across The Board'

Nov 5, 2025 06:08AM Baird Reiterates Underperform Rating on Amgen (AMGN), '3Q25 Financials Look Mostly Solid'

Nov 4, 2025 04:03PM Amgen (AMGN) Tops Q3 EPS by 60c, Offers Guidance

Nov 4, 2025 12:00PM Amgen is due to report after the bell on Tuesday. Here's what to watch out for.

Nov 3, 2025 10:35AM Amgen (AMGN) call put 1.6 calls to 1 put into quarter results

Oct 31, 2025 04:01PM Amgen (AMGN) Declares $2.38 Quarterly Dividend; 3.2% Yield

Oct 29, 2025 05:00PM ExxonMobil elects Gregory Garland to board of directors

Oct 22, 2025 08:42AM Tezspire wins EU approval for chronic rhinosinusitis with nasal polyps

Oct 17, 2025 04:11PM AstraZeneca's Tezspire gets FDA approval for nasal polyp condition

Oct 6, 2025 09:01AM AMGEN launches direct-to-patient program for cholesterol drug

Oct 3, 2025 06:32AM Bernstein: Positive VESALIUS-CV Data Is 'Great News for Amgen (AMGN)'

Oct 3, 2025 04:50AM Oppenheimer Reiterates Outperform Rating on Amgen (AMGN)

Oct 2, 2025 04:52AM Amgen (AMGN) 30-day option implied volatility flat

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

View Older Stories